CN1315477C - 注射用头孢呋辛钠与他唑巴坦钠组合物 - Google Patents
注射用头孢呋辛钠与他唑巴坦钠组合物 Download PDFInfo
- Publication number
- CN1315477C CN1315477C CNB200510090388XA CN200510090388A CN1315477C CN 1315477 C CN1315477 C CN 1315477C CN B200510090388X A CNB200510090388X A CN B200510090388XA CN 200510090388 A CN200510090388 A CN 200510090388A CN 1315477 C CN1315477 C CN 1315477C
- Authority
- CN
- China
- Prior art keywords
- sodium
- tazobactam
- cefuroxime
- injection
- staphylococcus aureus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
试验菌株 | A | B | C | D | E | F | G | H | I | J |
金黄色葡萄球菌 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 8 | 0.25 | 4 |
1 | 1 | 0.5 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | |
大肠埃希菌 | 4 | 4 | 2 | 2 | 4 | 4 | 8 | 128 | 0.5 | 4 |
2 | 2 | 1 | 2 | 2 | 4 | 4 | 128 | 2 | 1 | |
肺炎克雷伯菌 | 2 | 0.5 | 0.25 | 0.25 | 0.5 | 1 | 1 | 4 | 0.25 | 0.25 |
4 | 2 | 2 | 2 | 4 | 4 | 8 | 256 | 1 | 4 |
代码 | 试验菌株 | 药物含量 | 无药对照 | ||||||||||||
256 | 128 | 64 | 32 | 16 | 8 | 4 | 2 | 1 | 0.5 | 0.25 | 0.125 | 00625 | |||
A | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
B | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | - | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
C | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | - | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
D | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
E | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
F | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
G | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | + | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | + | + | + | + | + | + | + | + | |
H | 金黄色葡萄球菌 | - | - | - | - | - | - | + | + | + | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + |
大肠埃希菌 | - | - | + | + | + | + | + | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | + | + | + | + | + | + | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | + | + | + | + | + | + | + | + | + | + | + | + | + | |
1 | 金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | - | - | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | - | - | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | + | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | - | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
J | 金黄色葡萄球菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + |
金黄色葡萄球菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + | |
大肠埃希菌 | - | - | - | - | - | - | - | - | - | + | + | + | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | - | - | - | - | - | + | + | |
肺炎克雷伯菌 | - | - | - | - | - | - | - | + | + | + | + | + | + | + |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510090388XA CN1315477C (zh) | 2005-08-16 | 2005-08-16 | 注射用头孢呋辛钠与他唑巴坦钠组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510090388XA CN1315477C (zh) | 2005-08-16 | 2005-08-16 | 注射用头孢呋辛钠与他唑巴坦钠组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1732950A CN1732950A (zh) | 2006-02-15 |
CN1315477C true CN1315477C (zh) | 2007-05-16 |
Family
ID=36075706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510090388XA Ceased CN1315477C (zh) | 2005-08-16 | 2005-08-16 | 注射用头孢呋辛钠与他唑巴坦钠组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1315477C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327270B (zh) * | 2011-03-07 | 2013-06-26 | 深圳致君制药有限公司 | 一种β-内酰胺类复方抗生素组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513457A (zh) * | 2003-01-23 | 2004-07-21 | 深圳信立泰药业有限公司 | 抗β-内酰胺酶抗菌素复方制剂 |
CN1562040A (zh) * | 2004-03-15 | 2005-01-12 | 深圳市制药厂 | 头孢呋辛与他唑巴坦的组合物 |
-
2005
- 2005-08-16 CN CNB200510090388XA patent/CN1315477C/zh not_active Ceased
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513457A (zh) * | 2003-01-23 | 2004-07-21 | 深圳信立泰药业有限公司 | 抗β-内酰胺酶抗菌素复方制剂 |
CN1562040A (zh) * | 2004-03-15 | 2005-01-12 | 深圳市制药厂 | 头孢呋辛与他唑巴坦的组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN1732950A (zh) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rashmi et al. | Antibacterial resistance: current problems and possible solutions | |
Singh et al. | Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management | |
Sheth et al. | Antibiotic sensitivity pattern of bacterial isolates from the intensive care unit of a tertiary care hospital in India | |
Wiseman et al. | Cefprozil: a review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential | |
Zavascki et al. | Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit | |
CN1318033C (zh) | 注射用头孢呋辛钠与舒巴坦钠组合物 | |
Douidar et al. | Potential role of fluoroquinolones in pediatric infections | |
Mandell et al. | A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia | |
CN1315477C (zh) | 注射用头孢呋辛钠与他唑巴坦钠组合物 | |
Lynch III et al. | Infections Due to Acinetobacter baumannii–calcoaceticus Complex: Escalation of Antimicrobial Resistance and Evolving Treatment Options | |
WO2005120555A1 (fr) | Utilisation de lysozyme humain pour preparer un medicament destine au traitement de l'acne | |
CN101849947B (zh) | 一种头孢西酮钠和他唑巴坦钠的组合物及其配比 | |
Hamilton-Miller | The emergence of antibiotic resistance: myths and facts in clinical practice | |
CN1729983A (zh) | 头孢羟氨苄和β-内酰胺酶抑制剂的药物组合物 | |
CN1732949A (zh) | 注射用头孢呋辛钠与他唑巴坦钠组合物 | |
CN1742735A (zh) | 头孢呋辛酯口服抗菌组合物 | |
US20110166119A1 (en) | Synergistic Combinations of Aztreonam with the Carbapenems Meropenem and Ertapenem | |
Rodríguez-Guardado et al. | Ampicillin/sulbactam in combination: a review of its use in the treatment of severe bacterial infections | |
CN102462683B (zh) | 一种抗菌素组合物、其制备方法和用途 | |
Al-Dahmoshi et al. | Virulence and Antibiotic Resistance of Acinetobacter baumannii among Urinary Tract Infections | |
BALIGA | MIC distribution profile of newer antibiotics among gram-negative bacteria in a tertiary care centre | |
CN102125562B (zh) | 一种治疗超级细菌的注射用药物组合物 | |
Saikia et al. | Antibiotics: From Mechanism of Action to Resistance and Beyond | |
CN101912402B (zh) | 一种头孢西酮钠和克拉维酸钾的组合物及其配比 | |
Quintiliani et al. | Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hainan whole star Pharmaceutical Co., Ltd. Assignor: Xia Zhongning Contract fulfillment period: 2008.8.12 to 2025.8.16 contract change Contract record no.: 2008460000010 Denomination of invention: Composition of cefuroxime sodium and tazobactam sodium for injection Granted publication date: 20070516 License type: Exclusive license Record date: 2008.11.4 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.8.12 TO 2025.8.16; CHANGE OF CONTRACT Name of requester: HAINAN QUANXING PHARMACEUTICAL CO., LTD. Effective date: 20081104 |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20100628 Decision number of declaring invalidation: 15037 Granted publication date: 20070516 |